Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Stoppa

Showing results (71-80 of 99) with videos related to

Pageof 10
Sort By:
Annales De Genetique|April 24, 1999
[INSERM-FNCLCC collective expertise. Recommendations for medical management of women with genetic risk of developing breast and/or ovarian cancer]F Eisinger, N Alby, A Bremond, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 1998
Recommendations for medical management of hereditary breast and ovarian cancer: the French National Ad Hoc CommitteeF Eisinger, N Alby, A Bremond, et al.
Bulletin Du Cancer|April 22, 1999
[Inserm ad hoc committee: Recommendations for the management of women with a genetic risk for developing cancer of the breast and/or the ovary]F Eisinger, N Alby, A Bremond, et al.
Oncogene|September 13, 2003
Multiple molecular mechanisms contribute to radiation sensitivity in mantle cell lymphomaR M'kacher, A Bennaceur, F Farace, et al.
Gene|August 5, 2006
Structural organization and expression of human MTUS1, a candidate 8p22 tumor suppressor gene encoding a family of angiotensin II AT2 receptor-interacting proteins, ATIPM Di Benedetto, I Bièche, F Deshayes, et al.
Neuromolecular Medicine|January 17, 2013
Molecular defects in Moroccan patients with ataxia-telangiectasiaL Jeddane, F Ailal, C Dubois-d'Enghien, et al.
Pediatric Blood & Cancer|August 24, 2013
Malformations, genetic abnormalities, and Wilms tumorS Dumoucel, M Gauthier-Villars, D Stoppa-Lyonnet, et al.
Bulletin Du Cancer|September 16, 2009
[Cancer genetics: estimation of the needs of the population in France for the next ten years]C Bonaïti-Pellié, N Andrieu, P Arveux, et al.
British Journal of Cancer|September 30, 2010
Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutationL de Plater, A Laugé, C Guyader, et al.
Breast Cancer Research and Treatment|December 14, 2017
Assessment of the functional impact of germline BRCA1/2 variants located in non-coding regions in families with breast and/or ovarian cancer predispositionE Santana Dos Santos, S M Caputo, L Castera, et al.
Pageof 10

Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
Annales De Genetique|April 24, 1999
[INSERM-FNCLCC collective expertise. Recommendations for medical management of women with genetic risk of developing breast and/or ovarian cancer]F Eisinger, N Alby, A Bremond, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 1998
Recommendations for medical management of hereditary breast and ovarian cancer: the French National Ad Hoc CommitteeF Eisinger, N Alby, A Bremond, et al.
Bulletin Du Cancer|April 22, 1999
[Inserm ad hoc committee: Recommendations for the management of women with a genetic risk for developing cancer of the breast and/or the ovary]F Eisinger, N Alby, A Bremond, et al.
Oncogene|September 13, 2003
Multiple molecular mechanisms contribute to radiation sensitivity in mantle cell lymphomaR M'kacher, A Bennaceur, F Farace, et al.
Gene|August 5, 2006
Structural organization and expression of human MTUS1, a candidate 8p22 tumor suppressor gene encoding a family of angiotensin II AT2 receptor-interacting proteins, ATIPM Di Benedetto, I Bièche, F Deshayes, et al.
Neuromolecular Medicine|January 17, 2013
Molecular defects in Moroccan patients with ataxia-telangiectasiaL Jeddane, F Ailal, C Dubois-d'Enghien, et al.
Pediatric Blood & Cancer|August 24, 2013
Malformations, genetic abnormalities, and Wilms tumorS Dumoucel, M Gauthier-Villars, D Stoppa-Lyonnet, et al.
Bulletin Du Cancer|September 16, 2009
[Cancer genetics: estimation of the needs of the population in France for the next ten years]C Bonaïti-Pellié, N Andrieu, P Arveux, et al.
British Journal of Cancer|September 30, 2010
Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutationL de Plater, A Laugé, C Guyader, et al.
Breast Cancer Research and Treatment|December 14, 2017
Assessment of the functional impact of germline BRCA1/2 variants located in non-coding regions in families with breast and/or ovarian cancer predispositionE Santana Dos Santos, S M Caputo, L Castera, et al.
Pageof 10